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Selected Papers from the 2011 Summit on Translational BioinformaticsAMIA’s Fourth Summit on Translational Bioinformatics (TBI
Summit) was held in San Francisco from March 7–9, 2011. Dating
back to 2008, the Summit has become recognized as a key venue
for the exchange of ideas in translational bioinformatics. As in pre-
vious years, the 2011 TBI Summit highlighted the trans-disciplin-
ary nature of this now-burgeoning research ﬁeld and provided a
unique opportunity to bring together the ﬁnest minds in transla-
tional bioinformatics from academia, industry, government, and
non-proﬁt sectors. The 2011 TBI Summit focused on topics aligned
with four chosen themes: (1) informatics concepts, tools and tech-
niques to enable integrative translational bioinformatics research;
(2) informatics methods for the integrative analysis of molecular
and clinical measurements; (3) relating and representing pheno-
types and disease for translational bioinformatics research; and,
(4) informatics methods bridging basic science discoveries and
clinical practice.
In addition to the rich offering of scientiﬁc presentations
(including 3 tutorials, 8 panels, 48 podium presentations, and 69
poster presentations), the 2011 TBI Summit featured a number of
keynote presentations. Lincoln Stein, platform leader of Informat-
ics and Bio-computing at the Ontario Institute for Cancer Research,
delivered the opening keynote presentation on developing uniﬁed
approaches for managing biological and clinical data associated
with cancer. On the second day, award winning writer and lecturer
Carl Zimmer gave a presentation on the Human Microbiome. Russ
Altman, chair of bioengineering and professor at Stanford Univer-
sity, as well as the Principal Investigator for major TBI initiatives,
such as the Pharmacogenomics Knowledge Base (PharmGKB), sum-
marized the key advances in translational bioinformatics since the
last (2010) TBI Summit (also summarized in the Journal of the
American Medical Informatics Association [1]). Kenneth Buetow,
director of the National Cancer Institute’s Center for Bioinformatics
and Information Technology, delivered the ‘bridge day’ keynote on
developing national infrastructure to enable translational research
(which also served as the opening keynote for the partner Summit
on Clinical Research Informatics).
For the accepted full-length podium presentations, the top nine
were chosen for publication based on ranking submissions accord-
ing to reviewer submitted scores. The very best paper, as deter-
mined by an award committee (Russ Altman, Atul Butte, Riccardo
Bellazzi, Andrea Califano, Isaac Kohane, Yves Lussier, and Peter
Tarczy-Hornoch), received the ﬁrst Marco F. Ramoni Award. The
award was established to honor the memory of Marco Ramoni,
who passed away suddenly in June 2010. Dr. Ramoni was a friend
and colleague for many of us in the translational bioinformatics
ﬁeld as well as a major force behind the TBI Summit since its
inception. An extended version of this prize-winning paper was
published in the Journal of the American Medical Informatics1532-0464  2011 Elsevier Inc.
doi:10.1016/j.jbi.2011.11.014
Open access under CC BY-NC-ND license. Association [2]. The 2011 TBI Summit Track Chairs (Maricel Kann,
Lewis Frey, Nigam Shah, and Jessica Tenenbaum) vetted the
remaining eight distinguished paper candidates and they were
subjected to another round of full peer-review and revision before
being accepted for inclusion in this supplement. These eight papers
describe key informatics innovations that aim to directly address
challenges faced by the translational bioinformatics community.
The identiﬁcation of genes of interest or biomarkers associated
with complex disorders, such as autism spectrum disorders or
breast cancer, is a perennial challenge in the biomedical research
community. Meehan et al. [3] describe an ontology-based method
for determining candidate autism genes in the popular model
organism,Mus musculus (house mouse). Fabregue et al. [4] then de-
scribe an approach to identify molecular biomarkers that might be
used as prognostic or diagnostic tools in the context of breast can-
cer. These studies demonstrate how bioinformatics approaches
may offer promise towards a better understanding of the molecu-
lar underpinnings of disease, while still highlighting the key chal-
lenges that remain.
The identiﬁcation of key genes or features embodies a major
area in translational bioinformatics. However, the complexity of
many diseases or disorders requires robust validation as well as
new approaches for data exploration. Ganchev et al. [5] present a
framework for discovering biomarkers from multiple data sets
simultaneously. Bhavnani et al. [6] showcase network analysis ap-
proaches to explore co-occurrence relationships between cyto-
kines in asthma patients. As data acquisition techniques continue
to produce volumes of new data, such approaches for knowledge
integration and data exploration may become essential tools for
the translational bioinformatician.
Representation of biological and disease knowledge is an
essential component in many translational bioinformatics studies.
LePendu et al. [7] describe a feasibility study to develop a gene-
disease annotation data set (akin to the publicly available Gene
Ontology Annotation data set) for enabling statistical ranking of
disease genes. The promising ﬁndings by Ruau et al. [8] suggest
that automated tools may offer some solace in the data deluge of
largely un-annotated data sets. Scotch et al. [9] then demonstrate
how existing stores of biological knowledge (e.g., GenBank) can
be leveraged for secondary studies (e.g., phylogeography). Finally,
Tran et al. [10] describe a system that leverages ontological
approaches for representing disease information from multiple
clinical trial sites.
Collectively, the papers showcased here reﬂect the great
advances that translational bioinformatics is making towards
gaining a deeper understanding of the mechanisms associated with
human disease. The major thrust still remains in the development
of approaches to manage the large volumes of data that are being
S4 Editorial / Journal of Biomedical Informatics 44 (2011) S3–S4generated in the current era of higher and higher throughput tech-
nologies. However, the ﬁndings of all the papers presented here
echo a major theme that resounded across all the presentations
at the 2011 Summit on Translational Bioinformatics: Translational
Bioinformatics is increasingly focusing the rich array of bioinformatics
approaches towards a better understanding of human disease that
may ultimately lead to a new generation of prophylaxes, diagnostics,
and therapeutics.
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